Taken together, nuclear DNAJB6 plays a critical role in the development and lymph node metastasis of ESCC, reducing AKT signaling and suggesting its potential for development as a prognostic and therapeutic biomarker for ESCC [88]. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.